Seaport Therapeutics, Inc.
Research Seaport Therapeutics, Inc. (SPTX) on Bullrun: market cap USD 971.58M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSPTX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 971.58M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 25.41M
- Free cash flow-USD 20.17M
Valuation Snapshot
latest market cap is USD 971.58M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 74.88M | -USD 78.30M | n/a | -1.94 | USD 46.04M | USD 5.08M | -USD 92.55M |
| FY2024 | USD 0 | -USD 46.88M | -USD 29.74M | n/a | -1.21 | USD 309.10M | USD 5.01M | -USD 24.85M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 971.58M | n/a | n/a | n/a |
About Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. It is leveraging its proprietary Glyph platform to advance a pipeline of therapies to address the unmet needs in depression and anxiety.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Seaport Therapeutics, Inc.'s market cap?
Seaport Therapeutics, Inc.'s market capitalization is USD 971.58M.
What does Seaport Therapeutics, Inc. do?
Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. It is leveraging its proprietary Glyph platform to advance a pipeline of therapies to address the unmet needs in depression and anxiety.